31 March 2025
Persimmon Plc (the "Company")
Director/PDMR Shareholding
Persimmon Plc announces that on 28 March 2025 awards were granted to Dean Finch, Group Chief Executive, and Andrew Duxbury, Chief Financial Officer, over 59,854 and 31,122 shares respectively, under the Persimmon Plc 2020 Deferred Bonus Plan. The awards are for the deferred element of the Executive Directors' annual bonus and will ordinarily vest after a three-year period ending on the announcement of the Group's 2027 results.
In the case of Andrew Duxbury, this includes the deferred element of his bonus for the buy-out period prior to his joining Persimmon. Further details are included in the Persimmon Directors' Remuneration Report for the year ended 31 December 2024.
The below notification, made in accordance with the requirements of the UK Market Abuse Regulation, gives further details:
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name | Dean Finch | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Group Chief Executive | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, UK emission allowance market participant, auction platform or auctioneer
| ||||
| a)
| Name
| Persimmon Plc | |||
| b)
| LEI
| 213800XI72Y57UWN6F31 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| | Transaction 1 | | |||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
| | | ||||
| Identification code | GB0006825383 | ||||
| | | ||||
| b)
| Nature of the transaction
| Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Dean Finch's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.
| |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 59,854 | | |
| | |
| | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | N/A Single transaction | ||||
| | | ||||
| - Price | N/A Single transaction | ||||
| | | ||||
| e)
| Date of the transaction
| 28 March 2025 | |||
| f) | Place of the transaction | Outside a trading venue
| |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name | Andrew Duxbury | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Chief Financial Officer | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| Persimmon Plc | |||
| b)
| LEI
| 213800XI72Y57UWN6F31 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| | Transaction 1 | | |||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
| | | ||||
| Identification code | GB0006825383 | ||||
| | | ||||
| b)
| Nature of the transaction
| Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Andrew Duxbury's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.
| |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price(s) | Volume(s) | | |
| | | Nil | 31,122 | | |
| | |
| | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | N/A Single transaction | ||||
| | | ||||
| - Price | N/A Single transaction | ||||
| | | ||||
| e)
| Date of the transaction
| 28 March 2025 | |||
| f) | Place of the transaction | Outside a trading venue
| |||
Tracy Davison
Company Secretary
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.